SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000950123-04-008245
Filing Date
2004-07-07
Accepted
2004-07-07 17:20:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT #1 TO SCHEDULE 13G y98938a1sc13gza.txt SC 13G/A 13135
  Complete submission text file 0000950123-04-008245.txt   15081
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Subject) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-48459 | Film No.: 04904755
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE CHARLES CENTER 100 N. CHARLES ST BALTIMORE MD 21201
Business Address ONE CHARLES CENTER 100 N. CHARLES ST BALTIMORE MD 21201 4016492097
ANGELOS PETER G (Filed by) CIK: 0001241387 (see all company filings)